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VAN D A A L,  J. H. H. M.,  Y. J. M. DE K O K ,  B. G. J E N K S ,  S. E. W E N D E L A A R  B O N G A  A N D  J. H. F. VAN
A B E E L E N .  A genotype-dependent hippocampal dynorphinergic mechanism controls mouse exploration. P H A R M A C O L  
B IO C H E M  BEHAV 28(4)465-468. 1987.—Following microinjections with two dilutions o f  anti-dynorphin B antiserum into the 
hippocampal  CA3 region, adult  male mice from the inbred strains DBA/2 and C57BL/6 were individually tested for various 
explora tory  behaviors  in a novel environment  and com pared  to pre immune serum control  animals. T rea tm ent  augmented 
vert ically-oriented exploratory  acts in strain DBA/2 and reduced the scores  in strain C57BL/6 so that strain differences 
originally present  between the controls  were reversed or  eliminated after  antiserum. These  opposi te  effects indicate that a 
hippocampal  dynorphinergic  mechanism is involved in the regulation of  novelty-induced behavior  in mice and that its 
modulatory  function depends  on the genotype.  It is concluded that DBA/2 animals exposed  to novelty,  as com pared  to 
C57BL/6. are characterized by an over-release of  hippocampal dynorphin B which is neutralized in part by small amounts  of  
ant ibody.
H ippocam pus  Dynorphin B Antiserum Opioid Peptide Explora tory  behavior  Novel ty  
Genotype  Inbred strains Mouse
H IP P O C A M P A L  opioid peptides participate in the regula­
tion o f  explora tory  behavior  in rodents  [ 1 1 ]. There  is evi­
dence that exposure  o f  mice to environmental  novelty in­
duces release o f  opioids [ 10] and there are strong indications 
that such neuropeptides  act to disinhibit cholinergically- 
innervated pyramidal neurons in the C A 1 and CA3 regions of  
the h ippocampus by blocking inhibitory GABAergic  inter­
neurons [2,4]. The functioning of  these neuro transm it te r  sys­
tems depends  on the genotype,  as appears  from the opposite 
effects o f  in trahippocampal drug administrat ion upon the 
exploration rates o f  mice from the inbred strains DBA/2 and 
C57BL/6 [8,10]. The opiate antagonist  naloxone,  for ex am ­
ple, enhances  exploration in the normally low-scoring 
DBA/2 and reduces it in the normally high-scoring C57BL/6, 
leading to a reversal o f  the original strain difference [8]. The 
agonist morphine decreases  this behavior  in both strains [8]. 
These  observat ions  suggest that the regulatory mechanism 
concerned operates efficiently in C57BL/6 animals: treatment 
with either agonist or antagonist will upset its optimally bal­
anced peptidergic act ion,  thereby depressing exploration. 
With regard to DBA/2 mice exposed  to novelty,  however ,  
the above Findings point to a less efficient mechanism, imply­
ing an overshoot  in the release o f  one or  more hippocampal 
opioid peptides which is, naturally,  not alleviated by t rea t­
ment with an agonist but can be a t tenuated  by an appropria te  
inactivating agent: the latter will thus augment exploratory 
behavior.
One of  the opioids present in the h ippocampus is dynor­
phin B. As dem onstra ted  by others in rats [1, 3, 5, 6 , 12] and 
by us in mice (unpublished),  it is confined to the mossy fibers 
which project onto the CA3 area. To ascertain  the involve­
ment o f  this neuropeptide in the genotype-dependent  control 
o f  exploration,  we injected a highly specific anti-dynorphin B 
antiserum into the dorsal h ippocampus of  DBA/2 and 
C57BL/6 mice, which were then tested in a novel environ­
ment. This a t tempt to partly inactivate released neuropep­
tide was expected  to produce opposite effects on exploration 
rates in the two mouse strains. Our  purpose was to establish 
whether  an over-release of  hippocampal dynorphin  B in 
DBA/2 mice can be corrected  by this t rea tm ent  so that a 
more efficient disinhibition o f  exploratory  responses  to 
novelty becomes possible.
METHOD
Behavioral Testing
Labora tory  condit ions and behavioral recording methods 
were as described elsewhere [9,10]. Male mice, aged 13± 1 
weeks,  from the strains DBA/2JNmg and C57BL/6JNmg [7] 
were placed individually for 20 minutes into a novel en ­
vironment,  an illuminated observation cage (1 0 8 x 4 9 x 4 9  
cm), the floor o f  which was divided into 21  rectangles by 
painted lines and which contained a metal object a t tached 5 
cm above the floor. The frequencies o f  the following behav­
ioral acts were recorded: rearing (standing upright), incipient 
rearing, leaning against the wall, object-leaning, object-
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T A B L E  1
EXPLORATORY ACTS OBSERVED IN DBA/2 AND C57BU6 MICE INJECTED 
INTRAHIPPOCAMPALLY WITH CONTROL SERUM AND WITH TWO DILUTIONS 
OF ANT1-DYNORPHIN B ANTISERUM: DATA OBTAINED AFTER
W ELL-AIM ED INJECTIONS
Control 1/226 1/113
Rearing 
C57BL/6 
DBA/2 
p (strain)
51.3 ±  
23.5 ±
$
5.1
3.1
29.2 ±
43.1 ±
t
4.7* 
5. I t
31.0 ±  
44.9 ±
*
4 . I t  
4.8$
Incipient rearing 
C57BL/6 
DBA/2 
p (strain)
140.8 ±  
68.9 ±
*
7.7
3.8
96.0 ± 
103.7 ±
8.9$
7.5$
96.0 ± 
89.2 ±
7.9$
5.2+
Wall-leaning
C57BL/6
DBA/2
p (strain)
62.7 ± 
51.5 ±
*
3.7
3.6
64.0 ± 
70.9 ±
3.1
6.8*
64.6 ±
60.6 ±
4.0
4.3*
Locomotion  
. C57BL/6 
DBA/2 
p (strain)
467.7 ±  
394.0 ±
*
21.4
27.7
475.5 ± 
406.9 ±
27.1
38.3
481.5 ±  
435.4 ±
26.7
37.5
Floor-sniffing 
C57BL/6 
DBA/2 
p (strain)
160.2 ±  
203.7 ±
$
9.7
6.3
163.0 ±  
226.2 ±
+T
10.2
12.6
144.0 ±  
218.8 ±
$
7.7
11.4
Object-sniffing 
C57BL/6 
DBA/2 
p (strain)
24.1 ±  
16.8 ±
$
1.8
1.2
24.1 ±
19.2 ±
*
1.6
1.8
21.1 ±  
15.2 ±
X1
1.4
1.1
Object-leaning 
C57BL/6 
DBA/2 
p (strain)
5.0 ±  
3.7 ±
1.2
0.8
6.3 ±
4.4 ±
2.5
0.7
7.9 ± 
2.4 ±
1.8
0.6
Values are the mean ±  S .E .M . ;  n = 20 for each  group. Probabili ties as de te r ­
mined by Mann-Whitney U-tests ;  */?<0.05, Tp<0.01,  $/;<0.001.
sniffing, horizontal locomotion (line crossings),  and sniffing 
at the floor.
Antiserum
Because of  the localization of  dynorphin  B in the mossy 
fibers, the injections with its ant iserum should be placed into 
the CA3 region. The antiserum was raised against synthetic 
dynorphin B (Bachem, Bubendorf ,  Switzerland) which had 
been coupled to thyroglobulin with carbodiimide. Radioim­
m unoassays  showed this to be a C-terminal-directed 
antiserum with no cross-reactivity  to leucine- and 
methionine-enkephalin .
Injection Procedures
Fifteen minutes prior to testing, the anti-dynorphin B 
antiserum was injected stereotaxically ,  under  light e ther  
anesthesia ,  into the left dorsal  h ippocampus (total injection 
volume 0.5 p\). The 26S-gauge needle was introduced by 
piercing the skin, the skull, and the cerebral  cortex.  Using 
split litters, two dilutions o f  the an tiserum were chosen for 
the experimental  groups (n = 2 0  for each): 1/226 and 1/113, 
having binding capacities o f  9 and 18 pg o f  dynorphin  B,
respectively.  Since our  RIA determinat ions  revealed that 
one h ippocam pus contains  about 180 pg of  dynorphin  B (un­
published),  it is est imated that these antiserum dilutions can 
inactivate 5 to 10% of  the opioid. As control  groups (n =  20), 
animals injected with pre immune serum  (1/113) were used. It 
seems most unlikely that under  the experimental  condit ions 
the rabbit an t iserum would differ from the pre immune serum 
with respect  to horm ones  that could affect the behavior  of  
the experimental  mice. To check  the correc t  p lacement  of 
the injections, Evans  blue (0.3%) was added to the fluids. 
After the behavioral  observat ions  the brains were fixed by 
transcardial  perfusion with 4% paraformaldehyde and cryo- 
stat sections were examined.  Only animals in which the dye 
was limited to the CA3 region o f  the h ippocampus (61% of 
the cases) were included in the experiment .  We have been 
very strict in applying this criterion. Behavioral  influences of 
the injection procedure  per se have been reported  upon ea r ­
lier; these do not to any marked ex ten t  detract  from the 
strain differences [ 10].
RESULTS
Table 1 shows that both doses o f  the ant iserum enhanced
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T A B L E  2
EXPLORATORY ACTS OBSERVED IN DBA/2 AND C57BL/6 MICE INJECTED 
WITH CONTROL SERUM AND WITH TWO DILUTIONS OF ANTI-DYNORPHIN B 
ANTISERUM: DATA OBTAINED AFTER (PARTLY) MISDIRECTED INJECTIONS
Control 1/226 1/113
Rearing
C57BL/6 36.3 ± 6.0 43.1 ± 8.6 40.4 ± 5.9
DBA/2 32.5 ± 4.0 45.9 7.3 40.5 ± 6.6
/; (strain)
Incipient rearing
C57BL/6 112.1 ± 4.6 101.9 ± 12.7 104.2 ± 7.2
DBA/2 76.9 ± 5.2 93.2 ± 5.9 83.3 ± 10.8
p (strain) t
Wall-leaning
C57BL/6 65.9 ± 7.6 66.4 ± 7.4 78.5 ± 6.5
DBA/2 62.0 ± 6.7 59.9 ± 7.2 57.9 ± 8.4
p (strain) *
Locomotion
. C57BL/6 453.2 ± 30.4 457.1 45.4 515.9 ± 33.2
DBA/2 384.1 ± 18.6 394.0 40.2 411.9 ± 58.9
p (strain) *
Floor-sniffing
C57BL/6 153.7 ± 9.2 163.7 9.3 161.9 ± 9.0
DBA/2 187.2 ± 8.8 238.2 9.5* 215.6 ± 13.0
p (strain) t t JL»
Object-sniffing
C57BL/6 22.7 ± 2.2 20.7 ± 3.7 23.6 ± 1.4
DBA/2 19.0 ± 2.3 17.1 -f- 1.8 18.9 ± 2.4
p  (strain)
Object-leaning
C57BL/6 9.1 ± 2.7 13.0 4.4 13.5 ± 2.5
DBA/2 6.2 ± 1.3 4.3 1.4 5.1 ± 1.8
p (strain) t
Values  are the m ean  ±  S . E . M . ;  n = 9 - I 7 .  Probabi l i t ies  as d e te rm in e d  by 
Mann-Whitney U-tests;  *p<0.05 ,  t p < 0 . 0 1 ,  i p <0.001.
rearing significantly in strain DBA/2, whereas  strain 
C57BL/6 responded  with significant reductions.  The strain 
difference originally present  between the normal serum con­
trols was reversed  after these treatments .  As for incipient 
rearing, such opposi te  t rea tm ent  effects eliminated the origi­
nal strain difference. The antiserum did not reduce wall- 
leaning in C57BL/6 but it did increase this behavior  in 
DBA/2, leading to the d isappearance  of  the strain difference. 
With regard to locom otor  activity and floor-sniffing, the 
t rea tm ent  effects also tended to go in opposite  directions,  but 
not significantly, and for object-sniffing and object-leaning 
there was no such tendency.
DISCUSSION
Evidently ,  genetic influences are important  in hippocam- 
pally mediated behavioral  responses  to novelty and we have 
capitalized on this. Partial inactivation of  hippocampal 
dynorphin  B, released in mice exposed  to a novel environ­
ment,  caused  the reversal or  elimination o f  the differences 
be tw een  the two inbred strains, particularly as far as the 
vertically-oriented exploratory  acts are concerned .  The sig­
nificance o f  this finding is s trengthened by the fact that these
opposite  effects were not observed  at all in the groups 
(n=9-17)  discarded because of  partly or  entirely misdirected 
microinjections (see Table 2), i .e.,  the t rea tm ent  effects are 
specific to CA3. Hence,  the hypothesis  o f  a genotype- 
dependent  disinhibitory function of  hippocampal dynorphin 
B in the regulation of  mouse exploration, as outlined above,  
is strongly supported .  In strain C57BL/6, the presumptively 
balanced dynorphinergic action seems to be upset by 
antiserum administration. For  strain DBA/2, in contrast ,  an 
over-release o f  the opioid peptide apparently  can be neutral­
ized in part by t rea tment  with diluted antiserum, leading to 
higher exploration rates.
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